This episode of Pharmacy Focus: Policy Edition focuses on the DRUG Act and PBM reform efforts with Greg Baker, RPh, CEO of AffirmedRx. The DRUG Act aims to address unfair PBM practices like revenue-based compensation models that incentivize higher drug prices. Baker provides an overview of the key provisions in the legislation and their significance, and the implications of D-linking PBM compensation from drug list prices are also explored. Baker emphasizes the need for transparency in the PBM industry and advocates for fair pharmacist compensation.